Gynecologic Cancer News

The FDA granted fast track designation to several agents under investigation for the treatment of patients with certain solid tumors or hematologic malignancies.

Cancer led to 4 million potential years of life lost in 2017 in the United States, with cancers occurring in younger patients accounting for a disproportionate amount of the burden, according to study results.

Recreational physical activity appeared associated with improved survival outcomes among women with endometrial cancer, according to study results published in Journal of Clinical Oncology.

Lesbian, gay, bisexual, transgender or queer individuals, or sexual and gender minorities, have been shown to have a disproportionate risk for cancer.

The FDA approved the FoundationOne Liquid CDx test as a companion diagnostic device to help identify multiple additional biomarkers in cell-free DNA isolated from plasma, according to a press release from the agency.

Most cancer survivors reported experiencing some degree of sexual dysfunction after treatment, yet women were less likely than men to report being asked about sexual health by their health care provider, according to study results.

Image-guided intensity-modulated radiation therapy resulted in fewer gastrointestinal adverse events than 3D conformal radiation among women with cervical cancer, according to a phase 3 study presented at the virtual ASTRO Annual Meeting.

Self-sampling for HPV infection to screen for cervical cancer prevention would be a useful option for many at-risk individuals as an alternative to provider-collected HPV and cervical cytology.

Once the leading cause of cancer death among U.S. women, cervical cancer incidence and mortality have decreased substantially over the past 40 years, largely due to screening.

Women with invasive cervical cancer demonstrated increased risks for iatrogenic and noniatrogenic injuries during diagnostic workup, according to results of a study published in Cancer Epidemiology, Biomarkers & Prevention.